(Q28072144)

Masashi Kanai

2

1 reference

Shigemi Matsumoto

3

1 reference

Yasushi Okuno

4

1 reference

Manabu Muto

5

1 reference

language of work or name

1 reference

May 2016

1 reference

Japanese Journal of Clinical Oncology

published in

1 reference

volume

46

1 reference

issue

5

1 reference

page(s)

399-406

1 reference

Genetic instabilities in human cancers

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Two hundred years of cancer research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

The Global Burden of Cancer 2013

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Advances in understanding cancer genomes through second-generation sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

A decade's perspective on DNA sequencing technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Comprehensive molecular characterization of human colon and rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Emerging landscape of oncogenic signatures across human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

The somatic genomic landscape of chromophobe renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Integrated genomic characterization of papillary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Diagnostic clinical genome and exome sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Comprehensive molecular characterization of gastric adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Whole genomes redefine the mutational landscape of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Implementing personalized cancer genomics in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Designing transformative clinical trials in the cancer genome era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

A new initiative on precision medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Cancer Systems Biology: a peek into the future of patient care?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Developing precision medicine in a global world

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Impact of Precision Medicine in Diverse Cancers: A Meta-Analysis of Phase II Clinical Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

The Cancer Genome Atlas Pan-Cancer analysis project

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Genomic medicine frontier in human solid tumors: prospects and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Personalizing oncology: perspectives and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Non-Small Cell Lung Cancer, Version 6.2015.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

DNA sequencing with chain-terminating inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Initial sequencing and analysis of the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Deep sequencing in cancer research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Understanding next generation sequencing in oncology: A guide for oncologists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Existing and emerging technologies for tumor genomic profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

The FDA and genomic tests--getting regulation right

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Clinical applications of next generation sequencing in cancer: from panels, to exomes, to genomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Enabling a genetically informed approach to cancer medicine: a retrospective evaluation of the impact of comprehensive tumor profiling using a targeted next-generation sequencing panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Clinical next-generation sequencing in patients with non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Implications for KRAS status and EGFR-targeted therapies in metastatic CRC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

The molecular pathology of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

WNT signalling pathways as therapeutic targets in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Drugging the p53 pathway: understanding the route to clinical efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

The BATTLE trial: personalizing therapy for lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Molecular profiling and targeted therapy for advanced thoracic malignancies: a biomarker-derived, multiarm, multihistology phase II basket trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Detection and characterization of carcinoma cells in the blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Isolation of rare circulating tumour cells in cancer patients by microchip technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Cell-free nucleic acids as biomarkers in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Circulating tumour cells and cell-free DNA as tools for managing breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Circulating mutant DNA to assess tumor dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Analysis of circulating tumor DNA to monitor metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Challenges in initiating and conducting personalized cancer therapy trials: perspectives from WINTHER, a Worldwide Innovative Network (WIN) Consortium trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Big science: The cancer genome challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Mutational heterogeneity in cancer and the search for new cancer-associated genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

COSMIC: exploring the world's knowledge of somatic mutations in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Pilot study using molecular profiling of patients' tumors to find potential targets and select treatments for their refractory cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Personalized medicine in a phase I clinical trials program: the MD Anderson Cancer Center initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Personalized medicine for patients with advanced cancer in the phase I program at MD Anderson: validation and landmark analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Molecular tumor board: the University of California-San Diego Moores Cancer Center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Implementation of a Molecular Tumor Board: The Impact on Treatment Decisions for 35 Patients Evaluated at Dartmouth-Hitchcock Medical Center

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Genomics, health care, and society

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Ethical, legal, and counseling challenges surrounding the return of genetic results in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Targeted therapy in rare cancers--adopting the orphans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Cancer of unknown primary site.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

Cancer of Unknown Primary origin in the genomic era: Elucidating the dark box of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW018

21 January 2018

Identifiers

DOI

10.1093/JJCO/HYW018

0 references

PubMed publication ID

26917600

1 reference